For chromatography operations, meanwhile, adoption levels are mixed, says Lalit Saxena, senior director of MSAT at Samsung Biologics. He attributes this fact to the technical challenges to scaling, issues with the device size availability per batch size, and operational costs.
For chromatography operations, meanwhile, adoption levels are mixed, says Lalit Saxena, senior director of MSAT at Samsung Biologics. He attributes this fact to the technical challenges to scaling, issues with the device size availability per batch size, and operational costs.
- CDO
- CGMP
- ADC
- Bio Campus
- IR
- CMO
Share article